Ticker: LPTX

Leap Therapeutics, Inc. (NASDAQ: LPTX) - quick read on what's going on inside the company and the income statement highlights. Amounts below are presented in the company's filing format (in thousands, except share and per share amounts). Key facts & statistics - Cash and cash equivalents: $18,130...

Leap Therapeutics, Inc. (NASDAQ: LPTX) reported its financial progress for the quarter ending March 31, 2025. The company is focused on developing biomarker-targeted antibody therapies aimed at treating cancer. Positive Aspects: Research and development expenses increased by $1.6 million, driven...